Sensyne Health PLC is a leading healthcare technology company that focuses on improving patient outcomes. The company values innovation, collaboration, and ethical behavior in its pursuit of transforming healthcare through the use of artificial intelligence and clinical data analysis. Sensyne Health PLC strongly believes in the responsible and transparent use of patient data to drive breakthrough discoveries and enhance medical research. By partnering with the NHS and other healthcare organizations, Sensyne Health PLC aims to create value for patients, clinicians, and shareholders alike. With its commitment to putting patients at the center of its work, Sensyne Health PLC is dedicated to revolutionizing healthcare delivery for the benefit of all.

Sensyne Health PLC is primarily present in the United Kingdom (UK). As a leading digital health technology company, Sensyne Health operates in various regions within the UK, including England, Scotland, Wales, and Northern Ireland. With its headquarters in Oxford, Sensyne Health focuses on delivering innovative solutions to drive improvements in patient care and health outcomes. By leveraging advanced analytics, artificial intelligence, and clinical expertise, Sensyne Health aims to transform the way healthcare is delivered and managed.

Sensyne Health PLC, a prominent healthcare technology and artificial intelligence company, has achieved remarkable milestones throughout its journey. The company successfully secured a listing on the London Stock Exchange's Main Market in 2018. Moreover, it has entered into strategic collaborations with prestigious institutions like the University of Oxford and the South Warwickshire NHS Foundation Trust, bolstering its position in the healthcare industry. Sensyne Health has also gained recognition for its innovative data-driven solutions, focusing on improving patient outcomes and advancing precision medicine through machine learning algorithms. With an impressive track record, Sensyne Health PLC continues to make significant strides in transforming the healthcare landscape.

Sensyne Health PLC is a renowned healthcare technology company based in the United Kingdom. Established in 2018, the company specializes in the ethical application of clinical artificial intelligence to improve patient care and support medical research. Sensyne Health PLC collaborates with NHS Trusts and other healthcare organizations to develop secure, scalable, and regulatory-compliant digital health solutions. With a strong focus on data analysis, the company aims to harness the power of technology to enhance healthcare outcomes and expedite medical discoveries. Sensyne Health PLC continually strives to revolutionize the healthcare industry through innovation and transformative solutions.

The main competitors of Sensyne Health PLC in the market are other companies operating in the digital healthcare sector, such as Cerner Corporation, Allscripts Healthcare Solutions Inc., and Teladoc Health Inc. These companies offer similar digital health solutions and technologies, competing directly with Sensyne Health in terms of product offerings and market share. Additionally, other established healthcare technology companies could also be considered as competitors, depending on the specific services they provide. However, Sensyne Health PLC maintains a unique position in the market with its proprietary artificial intelligence technology and data analysis capabilities.

Sensyne Health PLC primarily operates in the healthcare and technology industries.

The business model of Sensyne Health PLC is focused on the development and application of artificial intelligence (AI) technology in healthcare. Sensyne Health combines clinical expertise with advanced data analytics to create new insights and solutions for the healthcare industry. By leveraging AI algorithms and machine learning, the company aims to unlock the value of patient data, enabling the discovery of novel insights and the development of innovative therapies and care pathways. Sensyne Health collaborates with patient groups, academic institutions, and healthcare providers to accelerate the development of personalized and data-driven healthcare solutions.

P/E odnos Sensyne Health iznosi 197,16.

KUV kompanije Sensyne Health iznosi 0,01.

AlleAktien kvalitativni skor za Sensyne Health je 4/10.

očekivana Sensyne Health promet je 75,76 mil. GBP.

Dobit očekivana Sensyne Health je 2.471,43 GBP.

Sensyne Health PLC is a leading digital health company that offers novel clinical decision support systems and artificial intelligence solutions for healthcare providers. With a focus on improving patient care through the application of data science, Sensyne Health provides personalized medical solutions tailored to the needs of patients, providers, and health systems.

Sensyne Health isplaćuje dividendu od 0 GBP raspoređenu preko isplata u toku godine.

Dividenda za Sensyne Health trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Sensyne Health je GB00BYV3J755.

WKN od Sensyne Health je A2N38D.

Oznaka za praćenje akcija kompanije Sensyne Health je SENS.L.

U poslednjih 12 meseci, Sensyne Health je isplatio dividendu u iznosu od . To odgovara dividendnom prinosu od oko . Za narednih 12 meseci, Sensyne Health će verovatno isplatiti dividendu od 0 GBP.

Dividendski prinos od Sensyne Health trenutno iznosi .

Sensyne Health isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima .

Sensyne Health je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0 GBP. To odgovara dividendnom prinosu od 0 %.

Sensyne Health se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Sensyne Health od 22. 7. 2024. u iznosu od 0 GBP, morali ste da imate akciju u depou pre Ex-dana 22. 7. 2024..

Isplata poslednje dividende izvršena je 22. 7. 2024..

U godini 2023 kompanija Sensyne Health je isplatila 0 GBP kao dividende.

Dividende od Sensyne Health se isplaćuju u GBP.